VivoSim Labs (NASDAQ:VIVS) hits $5M milestone; company says 500% revenue jump comes off $131K base
SAN DIEGO, July 15, 2026, 13:07 (PDT) Lilly’s payment is 38.2 times VivoSim’s 2026 fiscal revenue, and about 1.7 times the company’s closing equity value. (GlobeNewswire) B: The payment from Lilly…
Read the full articleYou might also wanna read
VivoSim receives $5M milestone payment from Eli Lilly
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Eli Lilly’s $400 Billion Surge Is Reshaping Big Pharma
Roughly $400 billion. That is how much market value Eli Lilly (NYSE:LLY) has added over the past year, with shares climbing from $773.86 on
Eli Lilly Revenue Surges 55.5% on Mounjaro Sales, But Stock Lags Amid Pricing Pressures
Eli Lilly reported strong revenue growth and raised full-year guidance, but pricing pressure and insider selling have limited the stock’s ne
briefly.co·27d agoDixon Technologies Gets Vivo JV Boost! Buy, Sell Or Hold? Expert Explains
Dixon Technologies is back in the spotlight after receiving government approval for its long-awaited joint venture with Vivo India. The part
India’s lifesciences sector sees momentum build in innovation: BCG -HealthKois report
Private equity and venture capital investment in pharma rose 2.1x in five years to $ 731 million for the year ended March 2026, and biotech
Hanmi Pharm Q2 Earnings to Improve on Lilly Upfront Payment
Hanmi Pharmaceutical is expected to beat Q2 expectations on a 112.9 billion won upfront payment from Eli Lilly, though core business recover
Comments
Sign in to join the conversation.
No comments yet. Be the first.